Association of Atherogenic Index of Plasma With Angiographic Progression in Patients With Suspected Coronary Artery Disease

Angiology. 2022 Nov-Dec;73(10):927-935. doi: 10.1177/00033197221080911. Epub 2022 Mar 1.

Abstract

The present study aimed to explore the correlation of atherogenic index of plasma (AIP) with angiographic progression of coronary artery disease (CAD). AIP was defined as the base 10 logarithm of the ratio of the triglyceride to high-density lipoprotein cholesterol concentration. The extent of coronary lesion was assessed by the Gensini Score (GS) system and angiographic progression was defined as the GS rate of change per year >1 point. A total of 896 patients with suspected CAD who underwent coronary computed tomography angiography twice at intervals of >6 months were included. Baseline AIP was positively correlated with remnant cholesterol (r = .644, P < .001). When patients were assigned into four groups according to baseline AIP quartiles, the incidence of CAD progression significantly increased across the quartiles of AIP (Q1 [lowest]: 23.7 vs Q2: 29.9 vs Q3: 33.9 vs Q4 [highest]: 34.8%; P = .042). After multivariate adjustment, the odds ratio for CAD progression was 1.89 when comparing the highest to the lowest quartile of AIP (95% confidence interval: 1.18-3.02; P = .008). Therefore, AIP was independently correlated with angiographic progression of CAD beyond conventional risk factors, suggesting that AIP may play a role in early risk stratification as a simple surrogate of residual risk.

Keywords: angiographic progression; atherogenic index of plasma; coronary artery disease; remnant cholesterol; residual risk.

MeSH terms

  • Arteries
  • Cholesterol
  • Cholesterol, HDL
  • Coronary Angiography
  • Coronary Artery Disease* / diagnostic imaging
  • Humans
  • Risk Factors
  • Triglycerides

Substances

  • Cholesterol, HDL
  • Triglycerides
  • Cholesterol